World Metastatic Prostate Cancer Drug Landscape Research
Dublin, April 18, 2024 (GLOBE NEWSWIRE) -- The
Stay updated with breaking news from Priority Review. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Dublin, April 18, 2024 (GLOBE NEWSWIRE) -- The
The FDA has accepted for Priority Review the New Drug Application for IB1001 for the treatment of Niemann-Pick disease type C.
· With a mortality rate of 20-30% for sepsis and 30-50% for septic shock in developed countries, sepsis represents an enormous public health burden and is responsible for almost 20% of all deaths worldwide· ...
With a mortality rate of 20-30% for sepsis and 30-50% for septic shock in developed countries, sepsis represents an enormous public health burden ...
WALTHAM - Syndax Pharmaceuticals , a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced the presentation of positive data from the pivotal...